Speaker Jeffrey C. Johnson, New Technology Lead, Sterile, Technology and Commercialization, Merck & Co., Inc. spent 1983-1984 cycling around the world. He also was leaded the Technology Transfer Team for Gardasil, a vaccine against cervical Cancer. Next week, he will be at the BioProcess International Conference and Exhibition presenting in the Best Practices for Implementation Challenges with Single Use Systems symposium on Monday, October 8.What sessions and speakers can you look forward to in this track?
- Evolution and Sustainability of Single Use Systems
- wRobert Repetto, M.S., MBA., Research Fellow, External Affairs, Pfizer BioTherapeutics Pharmaceutical Sciences; Chair, PDA Single-Use System Task Force
- Economics of Single Use Operations and Loss Risk
- wAndrew Sinclair, Managing Director, BioPharm Services Ltd., United Kingdom
- Material Understanding and Supplier Partnerships
- wDuncan Low, Ph.D., Scientific Executive Director, Amgen Inc.
- Using Single-Use Technologies to Improve Speed to Clinic: A Case Study Looking at Scalability as Well as Leachables and Extractables in a Fully Disposable Downstream Process
- wJoshua Hayes, Field Marketing Manager – Single Use Processing Systems, Biopharm Process Solutions, EMD Millipore
- Global Adoption of Single Use Technologies: Perspectives from an End User
- wJeffrey C. Johnson, New Technology Lead, Sterile Technology and Commercialization, Merck & Co., Inc.
BioProcess International will take place October 8-12 in Providence, Rhode Island. For more information on this program featuring over 180+ speakers, download the agenda here. Would you like to join us? Register today.
|
Share this article with your social network, just click below to share now!
|
|
|
No comments :
Post a Comment